AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
Global Drug of Abuse Testing Market (By Product Type, Sample / Test Type, Drug Type, End Users / Setting Type, Country Analysis), Regulatory Status, Recent Developments, Company Profiles - Forecast to 2032
... of abuse testing market was valued at US$ 6,973 Million in 2023, and is predicted to reach US$ 11,715 Million by 2032. The use of illicit drugs is increasing across the globe. An estimated 296 ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis, 2024-2029
... market trends is crucial for healthcare providers, investors, and industry stakeholders. This report offers a detailed analysis of the factors driving growth, including the increasing recognition of infectious diseases as a global health concern. As ... Read More
-
2024-2029 HIV/AIDS Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
... presents test volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan for HIV-1/2/Combo, HIV Ag, Western Blot and other confirmatory assays performed in the following markets: Blood ... Read More
-
2024-2029 Herpes Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Herpes Simplex I/II and Herpes Type VI tests performed in the ... Read More
-
2024-2029 Syphilis Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Blood Banks, Commercial and Public Health Labs, POC Locations
... volumes, sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Syphilis tests performed in the following market segments: Birth Centers ... Read More
-
2024-2029 Gonorrhea Molecular Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts and supplier shares for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Gonorrhea tests performed in the following market segments: Birth Centers - ... Read More
-
Global Herpes Zoster Therapeutics Market 2024-2028
... period. The report on the herpes zoster therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
2024-2029 Europe Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: France, Germany, Italy, Sp
... by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities This new report from LeadingMarketResearch.com provides analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and ... Read More
-
2024-2029 UK Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: Supplier Shares and Sales Segm
... Instrumentation and Opportunities About This Report This new LeadingMarketResearch.com presents detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and ... Read More
-
2024-2029 France Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: Supplier Shares and Sales
... Instrumentation and Opportunities About This Report This new LeadingMarketResearch.com presents detailed analysis of the French STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and ... Read More
-
2024-2029 Global Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: US, Europe, Japan - Suppli
... Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities This new report from LeadingMarketResearch.com provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles ... Read More
-
2024-2029 US Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: Supplier Shares and Sales Segm
... Instrumentation and Opportunities About This Report This new LeadingMarketResearch.com presents detailed analysis of the US STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and ... Read More
-
2024-2029 Italy Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: Supplier Shares and Sales S
... Instrumentation and Opportunities About This Report This new LeadingMarketResearch.com presents detailed analysis of the Italian STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and ... Read More
-
2024-2029 Germany Sexually-Transmitted Diseases (STD) Market for AIDS/HIV, Chancroid, Chlamydia, Gonorrhea, Granuloma Inguinale, Herpes I/II, Lymphogranuloma, Mycoplasma, Papillomavirus, Syphilis, and Trichomonas Vaginalis Tests: Supplier Shares and Sales
... Instrumentation and Opportunities About This Report This new LeadingMarketResearch.com presents detailed analysis of the German STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and ... Read More
-
Latent TB Testing Market by Test Type (Tuberculin Skin Test/TST, IGRA Test), Application (Household Contacts (HHC) of Tuberculosis (TB) Patients, People Living with HIV), End User (Diagnostic Labs, Hospitals), Region - Global Forecast to 2029
... The latent TB testing market will rise in value from estimated USD 582.5 million in 2024 to USD 773.4 million in 2029, at a CAGR of 5.8% over the forecast period. Increased funding and grants ... Read More
-
STD Testing
... at a CAGR of 5.2% over the analysis period 2023-2030. Chlamydia Testing, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of ... Read More
-
Herpes Zoster (Shingles) - Global Clinical Trials Review, 2024
... provides top line data relating to the clinical trials on Herpes Zoster (Shingles). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage ... Read More
-
Herpes Zoste Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application
... from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is presented from 2019 ... Read More
-
Asia-Pacific qPCR Market Research Report Information by Product & Services (Product & Services), by Application (Clinical, RUO, and Forensic), by Disease Type (Newborn Diseases, Respiratory, STI, Oncology, Gastroenteritis, Tropical Diseases, Herpes Virus Infections, Others), by End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others) Industry Forecast to 2032
... End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Pharmaceutical & Biotechnology Companies, Forensic Laboratories, Others) Industry Forecast to 2032 In 2022, the Asia Pacific Blood Glucose Monitoring Market Size was estimated to be USD ... Read More
-
Global Sexually Transmitted Diseases (STD) Treatment Market 2024-2028
... report on the sexually transmitted diseases (Std) treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
2024-2028 Global Herpes Testing (Simplex I/II, Type VI) in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation
... Regions and Countries Asia-Pacific Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam Europe Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, ... Read More
-
Anal Fistula Treatment
... by 2030, growing at a CAGR of 4.2% over the analysis period 2023-2030. The U.S. Market is Estimated at US$197.9 Million While China is Forecast to Grow at 4.1% CAGR The Anal Fistula Treatment market ... Read More
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
-
Sexually Transmitted Diseases (STDs) Drug
... Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. HPV Disease Drugs, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$74.3 ... Read More
-
Gonorrhea (GN): Competitive Landscape
... the 16 countries covered in GlobalData’s epidemiology forecast. Currently, the GN market contains many innovative therapies developed by big pharma giants. R&D efforts for GN are limited. Currently, 33 molecules are in the pipeline, with ... Read More
Research Assistance
